Sutro Biopharma (STRO) Current Taxes (2023 - 2024)
Sutro Biopharma (STRO) posted Current Taxes of $18000.0 for Q4 2024, little changed sequentially from $18000.0 in Q3 2024, and down 99.88% YoY from $15.2 million in Q1 2024.
Powered by 
Analysis
Sutro Biopharma (STRO) Current Taxes (2023 - 2024) Analysis & Trends
Sutro Biopharma has reported Current Taxes for 2 years, with the latest figure at $18000.0 in Q4 2024.
- Quarterly Current Taxes fell 99.88% year-over-year to $18000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $18000.0 (down 99.88% YoY) and the FY2024 annual result came in at $18000.0, down 99.88% from the prior year.
- Current Taxes was little changed at $18000.0 in Q4 2024 per STRO's latest filing, from $18000.0 in the prior quarter.
- Over five years, Current Taxes peaked at $15.2 million in Q4 2023 and troughed at $11000.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Sutro Biopharma | 333.09 Mn | 168.74 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 15.17 Mn |
| Dec 31, 2023 | 15.17 Mn |